Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,135 | 387 | 87.0% |
| Education | $915.78 | 3 | 13.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,575 | 112 | $0 (2024) |
| PFIZER INC. | $1,066 | 19 | $0 (2023) |
| GlaxoSmithKline, LLC. | $846.25 | 40 | $0 (2024) |
| Amgen Inc. | $403.26 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $361.16 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $297.42 | 18 | $0 (2024) |
| ABBVIE INC. | $289.34 | 17 | $0 (2024) |
| Lilly USA, LLC | $281.90 | 24 | $0 (2022) |
| Astellas Pharma US Inc | $232.01 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $219.26 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $733.06 | 40 | Novo Nordisk Inc ($208.03) |
| 2023 | $916.13 | 41 | GlaxoSmithKline, LLC. ($359.94) |
| 2022 | $644.21 | 39 | Novo Nordisk Inc ($170.65) |
| 2021 | $879.98 | 64 | Novo Nordisk Inc ($229.50) |
| 2020 | $693.88 | 49 | Novo Nordisk Inc ($222.25) |
| 2019 | $1,872 | 66 | PFIZER INC. ($891.41) |
| 2018 | $934.69 | 60 | Novo Nordisk Inc ($174.28) |
| 2017 | $377.27 | 31 | Novo Nordisk Inc ($115.07) |
All Payment Transactions
390 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: VACCINES | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: Medical Device | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: VACCINES | ||||||
| 09/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Endocrinology | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: UROLOGY | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), ROTARIX, FLUARIX QUADRIVALENT | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: VACCINES | ||||||
| 08/22/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diagnostics | ||||||
| 08/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Endocrinology | ||||||
| 08/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Biological | ||||||
| 07/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: UROLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Inflammation | ||||||
| 05/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Biological | ||||||
| 05/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,011 | 1,726 | $137,639 | $48,710 |
| 2022 | 26 | 1,103 | 1,933 | $125,914 | $46,365 |
| 2021 | 37 | 1,660 | 2,536 | $171,714 | $74,984 |
| 2020 | 22 | 1,433 | 2,236 | $166,295 | $65,197 |
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 226 | $51,980 | $16,287 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $17,490 | $6,083 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 84 | $13,272 | $3,880 | 29.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 53 | 53 | $3,922 | $3,696 | 94.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 25 | 25 | $9,425 | $3,084 | 32.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 79 | 145 | $5,800 | $2,337 | 40.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 79 | 146 | $4,672 | $1,801 | 38.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 48 | 58 | $4,002 | $1,609 | 40.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 79 | 149 | $3,129 | $1,514 | 48.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 52 | 52 | $2,444 | $1,479 | 60.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 83 | 163 | $2,184 | $1,266 | 58.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 80 | 148 | $2,812 | $1,111 | 39.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 108 | $6,264 | $1,031 | 16.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 25 | 25 | $2,875 | $910.32 | 31.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 48 | 48 | $2,400 | $791.48 | 33.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 31 | 60 | $1,380 | $533.12 | 38.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 21 | 21 | $903.00 | $397.32 | 44.0% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 12 | 15 | $915.00 | $278.19 | 30.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 17 | 18 | $648.00 | $266.04 | 41.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 12 | 15 | $315.00 | $114.92 | 36.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 15 | 15 | $300.00 | $79.43 | 26.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 15 | 15 | $195.00 | $66.04 | 33.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 64 | $192.00 | $64.34 | 33.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 20 | $120.00 | $30.80 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 218 | $48,340 | $16,207 | 33.5% |
About Dr. Wayne Stuart, DO
Dr. Wayne Stuart, DO is a Family Medicine healthcare provider based in Seymour, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225192099.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Stuart, DO has received a total of $7,051 in payments from pharmaceutical and medical device companies, with $733.06 received in 2024. These payments were reported across 390 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,135).
As a Medicare-enrolled provider, Stuart has provided services to 5,207 Medicare beneficiaries, totaling 8,431 services with total Medicare billing of $235,256. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Seymour, TN
- Active Since 12/19/2006
- Last Updated 02/27/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1225192099
Products in Payments
- Ozempic (Drug) $719.80
- JARDIANCE (Drug) $286.28
- Aimovig (Biological) $284.88
- SHINGRIX (Biological) $274.96
- FARXIGA (Drug) $253.20
- BEXSERO (Biological) $228.41
- VRAYLAR (Drug) $217.66
- Rybelsus (Drug) $213.36
- AREXVY (Drug) $189.10
- GEMTESA (Drug) $183.84
- Saxenda (Drug) $157.24
- TRULICITY (Drug) $151.07
- XIFAXAN (Drug) $143.84
- EMGALITY (Drug) $130.83
- TRINTELLIX (Drug) $113.53
- PNEUMOVAX 23 (Biological) $112.95
- SOLIQUA 100/33 (Biological) $112.67
- Tresiba (Drug) $104.11
- Trintellix (Drug) $95.53
- JANUVIA (Drug) $94.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Seymour
Dr. Wesley Payne, M.d, M.D
Family Medicine — Payments: $15,301
Garrett Rowe, Md, MD
Family Medicine — Payments: $8,632
Dr. Bradley Morin, M.d, M.D
Family Medicine — Payments: $8,001
Dr. Nicholas Lemming, Md, MD
Family Medicine — Payments: $7,667
Dr. David Hartung, Do, DO
Family Medicine — Payments: $7,097
Clay Stalcup, Md, MD
Family Medicine — Payments: $5,768